Meloxicam Lador Empifarma - Produtos Farmacêuticos (Meloxicam)

Meloxicam exerts its effect by selectively inhibiting the cyclooxygenase‑2 (COX‑2) enzyme, which is essential for the production of prostaglandins that drive inflammation, pain, and fever. By sparing COX‑1, it aims to lower inflammation while minimizing gastrointestinal side effects compared with non‑selective NSAIDs.

The appropriate dose of meloxicam is determined by the prescribing healthcare professional based on the patient’s condition, severity, age, renal and hepatic function, and other individual factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

The safety of meloxicam during pregnancy and lactation has not been definitively established. It is generally classified as contraindicated or used only when the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To request Meloxicam Lador Empifarma, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Meloxicam is a COX‑2‑selective NSAID, offering anti‑inflammatory and analgesic benefits similar to other agents such as ibuprofen or naproxen but with a potentially lower incidence of gastrointestinal irritation. However, it still carries cardiovascular and renal risks comparable to non‑selective NSAIDs, so the choice of agent should be individualized based on patient risk factors.

Meloxicam tablets should be stored at temperatures below 25 °C, in the original packaging, and protected from moisture and direct sunlight. Keep the product out of reach of children and do not use it after the expiry date printed on the label.

Meloxicam is taken orally, usually with a glass of water. It can be taken with or without food, but taking it with food may reduce stomach upset. The tablet should be swallowed whole and not split, crushed, or chewed unless specifically instructed by a healthcare professional.

Serious risks include gastrointestinal ulceration or bleeding, severe cardiovascular events such as heart attack or stroke, and liver injury indicated by elevated enzymes or hepatitis. Patients should seek immediate medical attention if they experience symptoms like black stools, sudden chest pain, shortness of breath, or jaundice.

Meloxicam should be avoided in individuals with known hypersensitivity to meloxicam or other NSAIDs, those with active gastrointestinal ulcers, severe heart failure, uncontrolled hypertension, or significant renal or hepatic impairment. It is also contraindicated in patients taking certain anticoagulants or other drugs that may cause dangerous interactions without close medical supervision.